Reichelt U - Search Results

1

[BeO-OSL detectors for dose measurements in cell cultures].

Andreeff M, Sommer D, Freudenberg R, Reichelt U, Henniger J, Kotzerke J. Andreeff M, et al. Among authors: reichelt u. Nuklearmedizin. 2009;48(6):227-32. doi: 10.3413/nukmed-0261. Epub 2009 Oct 26. Nuklearmedizin. 2009. PMID: 19862463 German.

2

Application of advanced Monte Carlo Methods in numerical dosimetry.

Reichelt U, Henniger J, Lange C. Reichelt U, et al. Radiat Prot Dosimetry. 2006;119(1-4):479-82. doi: 10.1093/rpd/nci682. Epub 2006 May 18. Radiat Prot Dosimetry. 2006. PMID: 16709706

3

[Swelling of the neck region].

Kutta H, Reichelt U, Wenzel S. Kutta H, et al. Among authors: reichelt u. HNO. 2007 Jul;55(7):557-9. doi: 10.1007/s00106-006-1536-y. HNO. 2007. PMID: 17415539 German. No abstract available.

4

[Leiomyoma. A rare neoplasia of the parotid gland].

Lehmann S, Tzamalis G, Reichelt U, Jovanovic S. Lehmann S, et al. Among authors: reichelt u. HNO. 2012 Jul;60(7):659-61. doi: 10.1007/s00106-012-2505-2. HNO. 2012. PMID: 22532283 German.

5

Serial monitoring of interleukin-1beta, soluble interleukin-2 receptor and lipopolysaccharide binding protein levels after death A comparative evaluation of potential postmortem markers of sepsis.

Reichelt U, Jung R, Nierhaus A, Tsokos M. Reichelt U, et al. Int J Legal Med. 2005 Mar;119(2):80-7. doi: 10.1007/s00414-004-0481-0. Epub 2004 Sep 4. Int J Legal Med. 2005. PMID: 15378307

6

Interleukin-6 and C-reactive protein serum levels in sepsis-related fatalities during the early postmortem period.

Tsokos M, Reichelt U, Jung R, Nierhaus A, Püschel K. Tsokos M, et al. Among authors: reichelt u. Forensic Sci Int. 2001 Jun 1;119(1):47-56. doi: 10.1016/s0379-0738(00)00391-1. Forensic Sci Int. 2001. PMID: 11348793

7

Serum procalcitonin (PCT): a valuable biochemical parameter for the post-mortem diagnosis of sepsis.

Tsokos M, Reichelt U, Nierhaus A, Püschel K. Tsokos M, et al. Among authors: reichelt u. Int J Legal Med. 2001;114(4-5):237-43. doi: 10.1007/s004140000177. Int J Legal Med. 2001. PMID: 11355402

8

Complementary use of fluorescence and magnetic resonance imaging of metastatic esophageal cancer in a novel orthotopic mouse model.

Gros SJ, Dohrmann T, Peldschus K, Schurr PG, Kaifi JT, Kalinina T, Reichelt U, Mann O, Strate TG, Adam G, Hoffman RM, Izbicki JR. Gros SJ, et al. Among authors: reichelt u. Int J Cancer. 2010 Jun 1;126(11):2671-81. doi: 10.1002/ijc.24980. Int J Cancer. 2010. PMID: 19847813

9

Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.

Kalinina T, Bockhorn M, Kaifi JT, Thieltges S, Güngör C, Effenberger KE, Strelow A, Reichelt U, Sauter G, Pantel K, Izbicki JR, Yekebas EF. Kalinina T, et al. Among authors: reichelt u. Int J Cancer. 2010 Oct 15;127(8):1931-40. doi: 10.1002/ijc.25196. Int J Cancer. 2010. PMID: 20104520

10

Midkine as a prognostic marker for gastrointestinal stromal tumors.

Kaifi JT, Fiegel HC, Rafnsdottir SL, Aridome K, Schurr PG, Reichelt U, Wachowiak R, Kleinhans H, Yekebas EF, Mann O, Ichihara-Tanaka K, Muramatsu T, Kluth D, Strate T, Izbicki JR. Kaifi JT, et al. Among authors: reichelt u. J Cancer Res Clin Oncol. 2007 Jul;133(7):431-5. doi: 10.1007/s00432-006-0180-y. Epub 2007 Jan 13. J Cancer Res Clin Oncol. 2007. PMID: 17221186

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters